WHO Backs Weight-Loss Drugs for Obesity The fight against obesity has been a long and arduous battle for many individuals around the world. With the World Health Organization (WHO) recently backing weight-loss drugs as a key component in the treatment of obesity, there is new hope on the horizon for those struggling to shed excess […]
WHO Adds Ozempic and Mounjaro to Essential Medicines List
WHO Adds Ozempic and Mounjaro to Essential Medicines List The World Health Organization (WHO) has taken a significant step in expanding global access to essential medicines by adding GLP-1 drugs to its prestigious list. This move comes as a part of WHO’s ongoing efforts to ensure that life-saving medications are available to all individuals worldwide, […]
Zepbound Beats Wegovy in First Head-to-Head Trial
Zepbound Triumphs Over Wegovy in Landmark Weight Loss Trial In the realm of weight loss medications, the competition is fierce, with pharmaceutical giants constantly vying to develop the most effective solutions for combating obesity. Recently, Eli Lilly’s GLP-1 drug Zepbound and Novo Nordisk’s Wegovy went head-to-head in a groundbreaking clinical trial to determine which medication […]
Novo Nordisk to Sell Wegovy Through Telehealth Firms
Novo Nordisk to Sell Wegovy Through Telehealth Firms In a strategic move to expand its market reach and streamline distribution, Novo Nordisk, a renowned pharmaceutical giant, has announced plans to collaborate with telehealth companies such as Hims & Hers and Ro. This partnership aims to facilitate the sale of Wegovy, one of Novo Nordisk’s groundbreaking […]
Pharmacists Urge Regulations Around Online Sale of GLP-1 Drugs
Pharmacists Call for Stricter Regulations on Online Sale of GLP-1 Drugs The National Pharmacy Association has recently raised concerns about the online sale of GLP-1 drugs, specifically weight-loss injections. As the demand for these drugs is expected to surge, pharmacists are urging for stricter regulations and mandatory consultations to ensure patient safety remains a top […]